Agencies planning to use ribavirin, should be provided with rapid methods for identifying antigen respiratory syncytial virus in respiratory secretions. These tests should be used in children when they reach the hospital. The traditional allocation of the virus in tissue culture may be useful to obtain epidemiological information about the circulation of respiratory syncytial virus in the community, but may not provide enough quick results for a decision on the use of ribavirin. If there are no tests, the treatment of ribavirin patients showed all three categories with bronhiolitom or pneumonia, which come a hospital in the season respiratory syncytial virus infections (from December to April).
Treatment can be terminated if the child’s lung disease was caused not by respiratory syncytial virus. However, ribavirin can be effective and with flu. If you are unable to identify the cause and the most likely clinical diagnosis remains respiratory viral infections, and the child’s grave, we recommend continued treatment to identify the cause. Although the allocation of the virus may require more than 7 days, treatment should not last longer than the normal rate (3-7 days). Especially important to confirm the diagnosis respiratory syncytial virus infection in children in the controlled breathing.
The use of drugs. Ribavirin sprayed in a tent or mask of a solution containing 20 mg ribavirin per 1 ml of water, using fine inhalers, delivered by the manufacturer, together with the drug. Aerosol applied for 12-18 hours a day for 3-7 days. In control studies for most children, there was improvement on the 3-5 day